HCS
SBBP

Harvest Capital Strategies’s Strongbridge Biopharma plc. SBBP Stock Holding History

Harvest Capital Strategies’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-543,652
Closed -$2.44M – 43
2018
Q4 		$2.44M Sell
543,652
-356,348
-40% -$1.74M 0.68% 38
2018
Q3 		$4.37M Sell
900,000
-67,243
-7% -$344K 0.5% 33
2018
Q2 		$5.8M Buy
967,243
+142,243
+17% +$1.04M 0.82% 24
2018
Q1 		$7.3M Buy
+825,000
New +$6.18M 1.14% 22

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Harvest Capital Strategies's SBBP Position: Q1 2019 in Review

Harvest Capital Strategies sold out of Strongbridge Biopharma plc. (SBBP) in Q1 2019, closing a stake of 543,652 shares — an estimated $2.44M sold.

Harvest Capital Strategies first reported a position in SBBP in Q1 2018 and held it in 4 quarters. The position peaked at $7.3M in Q1 2018. 51 funds tracked by Wall St. Rank hold SBBP as of Q1 2019.

  • Harvest Capital Strategies reported no remaining Strongbridge Biopharma plc. position as of Q1 2019 after selling out during the quarter.
  • Harvest Capital Strategies sold 543,652 Strongbridge Biopharma plc. shares in Q1 2019, an estimated $2.44M.
  • Harvest Capital Strategies first reported a position in Strongbridge Biopharma plc. in Q1 2018 and held it in 4 quarters.
  • Harvest Capital Strategies's Strongbridge Biopharma plc. position peaked at $7.3M in Q1 2018.
  • 51 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q1 2019.

Based on Harvest Capital Strategies's 13F filing for Q1 2019, filed 14 May 2019.